Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Chicago National Institutes of Health (NIH) |
---|---|
Information provided by: | University of Chicago |
ClinicalTrials.gov Identifier: | NCT00145977 |
The purpose of this study is to determine if a new test for osteoporosis can be useful in monitoring treatment. We are studying a new method for examining the quality of bone by an experimental method of computerized analysis of radiographic images (x-ray pictures) of the heel.
Condition | Intervention |
---|---|
Osteoporosis Osteopenia |
Drug: Alendronate 70mg |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Factorial Assignment, Efficacy Study |
Official Title: | Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis |
Estimated Enrollment: | 40 |
Study Start Date: | July 2001 |
Estimated Study Completion Date: | July 2010 |
Ages Eligible for Study: | 59 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
All study participants will be:
Exclusion Criteria:
Contact: Tamara Vokes, MD | 773-702-1465 | tvokes@medicine.bsd.uchicago.edu |
Contact: Ann Pham | 773-702-1197 | apham@medicine.bsd.uchicago.edu |
United States, Illinois | |
The University of Chicago | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: Tamara Vokes, MD 773-702-1465 tvokes@medicine.bsd.uchicago.edu | |
Contact: Ann Pham 773-702-1197 apham@medicine.bsd.uchicago.edu | |
Principal Investigator: Tamara Vokes, MD |
Principal Investigator: | Tamara Vokes, MD | University of Chicago |
Study ID Numbers: | IRB# 11009B, NIH AR42739, NIH AR42739-S1, NIH K23 |
Study First Received: | September 1, 2005 |
Last Updated: | March 16, 2007 |
ClinicalTrials.gov Identifier: | NCT00145977 |
Health Authority: | United States: Institutional Review Board |
osteoporosis bone density women |
endocrine musculoskeletal metabolic |
Musculoskeletal Diseases Alendronate Osteoporosis, Postmenopausal |
Osteoporosis Bone Diseases, Metabolic Bone Diseases |
Physiological Effects of Drugs Bone Density Conservation Agents Pharmacologic Actions |